![]() Back to Conference page
|
UICC World Cancer Congress 2006Bridging the Gap: Transforming Knowledge into ActionJuly 8-12, 2006, Washington, DC, USA |
Methods: 70 CRC patients and 121 non-cancer controls were included in this study. According to their Brinkman Index (BI), the individuals were divided into non-smoking (BI=0) and smoking (100≤BI≤1200) groups. The genotypes of NAT2, MYH, OGG1 and APE1 were determined by using PCR-RFLP method. Fisher′s Χ2-test was applied to compare the frequencies of genotypes in different groups and odds ratio (OR) was also calculated.
Results: In non-smoking group, frequency of rapid genotype of NAT2 was higher in CRC patients than controls (OR=5.9, 95%CI 2.0-17.6, P=0.001). And frequency of Gln/Gln genotype of MYH was higher in CRC patients than controls in non-smoking group (OR=5.7, 95%CI 1.4-22.8, P=0.011) and in smoking group (OR=10.4, 95%CI 2.1-50.4, P=0.002). In addition, in smoking group, frequency of Asp/Glu genotype of APE1 was higher in CRC patients than controls (OR=5.9, 95%CI 2.2-16.3, P=0.0003). Our findings suggested that polymorphisms of NAT2, MYH and APE1 gene were associated with risk of CRC in a Japanese population, and their association was effected by smoking.
See more of Public Health, Prevention and Education
See more of Public Health Prevention and Education
See more of The UICC World Cancer Congress 2006
